Roseville biopharmaceutical company offers money for stool donations

Roseville company pays for stool donations

ROSEVILLE, Minn. — You've heard about donating blood, plasma, or even organs. But there's a bio-pharmaceutical company in Roseville that's offering money for people to donate their stool.

Ignacio Cabrera helps lead Rebiotix's donor program, in which people drop by to drop off a donation; people poop in one of their bathrooms and then get paid for it.

"We're really embracing the awkwardness of this. It's uncomfortable to speak about poop - just saying poop sometimes is awkward, it's funny, but it's helpful here," he said. 

The company compensates $30 per qualifying donation. They're also compensated $50 for taking a COVID test.

Donors can visit up to twice a day for a maximum of 14 donations per week. No appointment is necessary; you can just walk in. The donors also take a COVID test every two weeks and a blood screening every six weeks.

MORE NEWS: Mystery illness spreading among dogs nationwide

Patricia Alonso was suffering from Clostridioides difficile —or C. diff. - a germ that infects the colon. Nearly half a million Americans suffer from it each year, and the symptoms are debilitating, even life-threatening. 

"I had extreme diarrhea. I was weak. I barely got off of the couch and I couldn't leave the house because I had to use the restroom so often," Alonso said.

C. diff is also contagious - meaning she couldn't touch her children. Antibiotics helped her the first time, but not for long.

"I experienced my first recurrence a month later. I was put on a different course of antibiotics, the symptoms went away. Three weeks later, it came back again," she said.

Lindy Bancke works for Ferring Pharmaceuticals - Rebiotix's parent company. She says there's a 35% chance a patient who had C. diff. will get it again.

If it does come back, there's a 65% chance it will recur.

Antibiotics treat C. diff. - but they also disrupt the delicate balance in a person's gut - leading to recurrences.

Rebiotix and Ferring wanted to break that cycle with unique research.

"The gut microbiome is one that we actually sometimes refer to as a gut garden. It is a finely balanced, delicately balanced community of trillions of live microbes," Bancke explained.

For a patient with recurring C. diff - the good microbes are missing in their gut - making them sick. But if those microbes are replenished -  the patient can recover.

And where can you find those good microbes? In a healthy person's poop.

Alonso took part in a Rebiotix trial — for what would become Rebyota — the first single-dose FDA-approved treatment for recurring C. diff.

In the four years since - she hasn't had one recurrence.

"I'm so grateful for the donors. They made a huge impact on my life," Alonso said.

All from a small deed — and rigorous work behind the scenes turning that donation — into a life-saving treatment.

While the money is nice for donors - Cabrera says it's the mission - that often becomes the motivation.

The FDA approval for Rebyota happened about a year ago. So with production ramping up — Rebiotix is needing more donors.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.